The Invesco S&P International Developed Quality ETF (IDHQ) is an exchange-traded fund that invests in stocks from developed markets outside the United States, selected and weighted based on quality metrics. The fund tracks the S&P International Developed Quality Index, which screens constituents of the S&P International Developed BMI Index for three fundamental quality factors: high return-on-equity (ROE), low financial leverage, and stable earnings growth over the preceding five years.
IDHQ's portfolio is heavily concentrated in developed international markets, with significant exposure to Japan, the United Kingdom, Canada, Switzerland, and the Eurozone. Top holdings typically include multinational blue-chip names such as Novo Nordisk, ASML Holding, Nestlé, Roche Holding, and Novartis. The ETF provides U.S. investors with a way to access high-quality international equities without taking on the currency and single-stock risks associated with direct foreign investment.
The $35 level has emerged as a focal point in discussions about IDHQ because it represents a notable round-number threshold that sits well above the ETF's historical trading range. For an ETF that has spent much of its recent history trading between $25 and $31, the $35 mark would require a breakout of approximately 15–20% from typical levels—a move that would signal a meaningful shift in the international equity landscape.
Investor interest in this target is also fueled by the broader narrative around international diversification. With U.S. equity valuations remaining elevated relative to historical norms, many market participants are questioning whether developed international markets—particularly those filtered for quality—might be poised for a period of catch-up performance. The $35 level serves as a convenient benchmark for that thesis.
Several catalysts would need to align for IDHQ to realistically approach the $35 mark. First and foremost, a sustained weakening of the U.S. dollar would provide a powerful tailwind. Since IDHQ holds foreign-currency-denominated assets, a declining dollar directly boosts returns for U.S.-based investors. If the Federal Reserve pivots to rate cuts while other major central banks hold steady or tighten, the resulting currency dynamics could meaningfully lift IDHQ's net asset value.
Second, the quality factor itself must continue to deliver. IDHQ's methodology emphasizes companies with strong balance sheets and consistent profitability—characteristics that tend to perform well during periods of economic uncertainty or when investors rotate toward defensive, high-quality names. If global economic growth slows but avoids a deep recession, quality-oriented international stocks could benefit from a flight-to-safety bid.
Third, a re-rating of international equities relative to U.S. stocks would be a significant catalyst. For years, U.S. markets have commanded a substantial valuation premium over developed international markets. Any narrowing of that gap—driven by improved earnings growth in Europe, successful stimulus measures in Japan, or simply mean reversion—would directly benefit IDHQ's underlying holdings.
From a technical analysis perspective, IDHQ faces several important levels on the path to $35. The ETF has encountered resistance near the $31–$32 range in prior rally attempts, making this zone a critical hurdle. A decisive breakout above $32 on strong volume would be the first signal that a move toward $35 is technically viable.
Beyond $32, the $33–$34 range represents relatively uncharted territory where the ETF would be trading at all-time highs. Without established support levels in this zone, price discovery could be volatile. The $35 level itself serves as both a psychological round number and a potential resistance point where profit-taking might emerge.
On the downside, support near $28–$29 has held during recent pullbacks, providing a foundation for any potential advance. A breakdown below this support zone would likely invalidate the near-term case for reaching $35.
Several significant headwinds could keep the $35 target out of reach. A strengthening U.S. dollar remains the most immediate threat—if the Federal Reserve maintains higher interest rates for longer than markets anticipate, dollar strength could persist and erode returns from international equities.
Additionally, the quality factor can underperform during strong risk-on rallies when investors favor lower-quality, higher-beta names. If global markets enter a sustained bull phase driven by speculative appetite rather than fundamental improvement, IDHQ's quality-focused portfolio might lag broader international benchmarks.
Geopolitical risks also loom large. IDHQ's significant exposure to European and Japanese equities means that regional economic weakness, energy price shocks, or trade disruptions could disproportionately impact the fund's holdings. The ETF's concentration in developed markets offers some insulation from emerging-market volatility but does not eliminate country-specific risks.
While individual ETFs do not receive traditional analyst price targets, the underlying holdings of IDHQ have drawn considerable attention from global research desks. Many of the fund's top constituents—including large-cap pharmaceutical, technology, and consumer staples companies—carry favorable analyst ratings, supported by strong balance sheets and consistent earnings growth. However, the aggregate upside implied by consensus price targets on these holdings suggests a more modest appreciation potential than what a move to $35 for IDHQ would require, unless accompanied by significant currency tailwinds.
The broader outlook for international developed equities remains mixed. European markets face structural challenges including demographic headwinds and fiscal uncertainty, while Japanese equities have benefited from corporate governance reforms but remain sensitive to yen fluctuations and Bank of Japan policy normalization.
Navigating the complexities of international equity ETFs requires timely and data-driven insights. AI Daily Buy/Sell Signals from Tickeron provide traders with continuously updated technical analysis and trading signals across thousands of stocks and ETFs, including international equity funds like IDHQ. The platform's artificial intelligence monitors market conditions in real time, generating Buy, Sell, or Hold signals based on a combination of technical indicators, trend analysis, and AI-driven pattern recognition. This allows investors to identify potential entry and exit points, track shifting market sentiment, and manage positions with greater confidence. For those looking to stay ahead of market movements without constant manual chart analysis, AI Daily Buy/Sell Signals offer an efficient, data-driven approach to decision-making.
The question of whether IDHQ can reach $35 is ultimately a question about the convergence of multiple favorable factors. The target is not unrealistic over a multi-year horizon, but it requires a scenario where international developed-market equities outperform, the quality factor delivers above-average returns, and the U.S. dollar weakens meaningfully. The strongest argument in favor of the move is the ETF's quality-focused methodology, which provides a structural advantage during uncertain economic periods. The biggest obstacles are persistent dollar strength and the possibility that international equities continue to lag behind U.S. markets. Investors should monitor currency trends, relative performance between U.S. and international markets, and IDHQ's ability to break through the $31–$32 resistance zone as key indicators of whether the path to $35 is opening or closing.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, IDHQ has been closely correlated with EFG. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if IDHQ jumps, then EFG could also see price increases.
| Ticker / NAME | Correlation To IDHQ | 1D Price Change % | ||
|---|---|---|---|---|
| IDHQ | 100% | -1.06% | ||
| EFG - IDHQ | 94% Closely correlated | -1.77% | ||
| IQDG - IDHQ | 93% Closely correlated | -0.83% | ||
| CGIE - IDHQ | 93% Closely correlated | -1.34% | ||
| CGXU - IDHQ | 90% Closely correlated | -2.37% | ||
| DNL - IDHQ | 87% Closely correlated | -1.57% | ||
More | ||||